GSA CAPITAL PARTNERS LLP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 37 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$232
-60.6%
88,923
-46.0%
0.02%
-66.1%
Q2 2023$589
+6.3%
164,596
+257.5%
0.06%
-14.5%
Q4 2022$554
-98.9%
46,039
+134.2%
0.07%
+666.7%
Q3 2020$51,00019,6590.01%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders